# Arzeda

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/arzeda

- Industry: Biopolymers
- Headquarters: Seattle, US
- Website: www.arzeda.com/
- Total disclosed funding: $76M
- Latest round: Series B (Aug 8, 2024)
- Investors on record: 16

## About

Founded in 2008 and based in the US, Arzeda Corp. specializes in synthesizing innovative proteins and enzymes, leveraging advanced technology to provide solutions for diverse industries, including food production and sustainable materials. Arzeda Corp. focuses on the design and development of advanced protein solutions. The company has completed 9 deals to date, with its most recent funding round, In September 2025, Arzeda Corp. recieved USD 7.8 million in grand funding from returning investor National Science Foundation.

Arzeda specializes in the design and development of innovative proteins and enzymes through its proprietary Intelligent Protein Design Technology™. This technology integrates physics-based protein design with advanced artificial intelligence to create unique designer proteins that address critical challenges across various industries, including food production, sustainable materials, and personal care. Arzeda's flagship product, ProSweet RebM, enhances the sweetness of stevia while improving taste and cost-performance, targeting the food and beverage industry. The company collaborates with major clients such as IFF, L’Oreal, and P&G to optimize supply chains and enhance product offerings, with a market presence across North America, Europe, and Asia.

Arzeda's revenue model is built on partnerships, collaborations, and B2B transactions with industry players. The company engages in joint development agreements to co-create tailored protein solutions, fostering long-term relationships that yield ongoing revenue streams. These agreements often involve shared research and development costs, enabling Arzeda to monetize its technology while clients benefit from customized applications of designer proteins and enzymes, with pricing structures based on design complexity and production scale.

The company will use the funding to accelerate the development of electricity-driven, cell-free biomanufacturing using AI-designed enzymes, positioning Arzeda to scale sustainable production technologies and broaden commercial applications across multiple industries.

## Funding rounds

- Series B, Aug 8, 2024, $23M — Sofinnova Partners, Continental Grain Company, W.L. Gore & Associates, Inc., Fall Line Capital, Lewis & Clark Ventures, Bunge Ventures, Sucden Ventures
- Series B, Jul 8, 2021, $26M — Casdin Capital, Awaken Capital, Lewis & Clark Ventures, Universal Materials Incubator, Planetary Technologies, Circulate Capital, Conti Ventures, Bunge Ventures
- Series A, Nov 28, 2017, $3.2M — Casdin Capital, Universal Materials Incubator
- Series A, Jul 20, 2017, $12M — WRF Capital, Sustainable Conversion Ventures, Awaken Capital, Planetary Technologies
- Seed, Feb 27, 2009, $12M — OVP Venture Partners, WRF Capital

## Investors

- OVP Venture Partners (https://capitalatlas.ai/funds/ovp-venture-partners) — Seed
- WRF Capital (https://capitalatlas.ai/funds/wrf-capital) — Seed, Series A
- Sustainable Conversion Ventures — Series A
- Awaken Capital (https://capitalatlas.ai/funds/awaken-capital) — Series A, Series B
- Planetary Technologies (https://capitalatlas.ai/funds/planetary-technologies) — Series A, Series B
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A, Series B
- Universal Materials Incubator (https://capitalatlas.ai/funds/universal-materials-incubator) — Series A, Series B
- Lewis & Clark Ventures (https://capitalatlas.ai/funds/lewis-clark-ventures) — Series B
- Circulate Capital (https://capitalatlas.ai/funds/circulate-capital) — Series B
- Conti Ventures — Series B
- Bunge Ventures — Series B
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series B
- Continental Grain Company (https://capitalatlas.ai/funds/continental-grain-company) — Series B
- W.L. Gore & Associates, Inc. — Series B
- Fall Line Capital (https://capitalatlas.ai/funds/fall-line-capital) — Series B
- Sucden Ventures (https://capitalatlas.ai/funds/sucden-ventures) — Series B